Active — Not RecruitingNot Applicable

A Prospective Incident Study of Arrhythmias in Hypertrophic Cardiomyopathy

United States260 participantsStarted 2019-11-05

Plain-language summary

The purpose of this research study is to understand more about various heart rhythms (electrical problems) in persons with hypertrophic cardiomyopathy with and without sleep apnea.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Currently or previously enrolled in 17-003514 and 16-009474 * Adults age \>18 years-old with a diagnosis of hypertrophic cardiomyopathy * Both sexes * Able to consent Exclusion Criteria: * Vulnerable study population * Known atrial fibrillation or flutter (with the exception of post-operative atrial fibrillation) * Pacemaker/ICD implantation * Pregnancy

What they're measuring

Atrial fibrillation incidence in hypertrophic cardiomyopathy

Timeframe: Final incidence to be calculated at study conclusion, after 3 years of rhythm monitoring.

Atrial fibrillation recurrence in hypertrophic cardiomyopathy

Timeframe: Final recurrence rate to be calculated at study conclusion, after 3 years of rhythm monitoring.

Ventricular arrhythmia incidence in hypertrophic cardiomyopathy

Timeframe: Final incidence to be calculated at study conclusion, after 3 years of rhythm monitoring.

Trial details

NCT IDNCT04112290

SponsorMayo Clinic

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-12

View on ClinicalTrials.gov More Hypertrophic Cardiomyopathy trials